Bridgewater Advisors Inc.

Position in ARGX — Argenx SE

CIK 1600319 NEW YORK, NY

Position in ARGX

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$310,802

+$66,899 QoQ

Shares Held

335

+0.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#349

of 504 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bridgewater Advisors Inc. holds $1,270,177 across 4 Biotechnology names. ARGX ranks #2 (24.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,103	$547,893
2	ARGX	Argenx SE This page	335	$310,802
3	REGN	Regeneron Pharmaceuticals, Inc.	340	$212,003
4	TTRX	Turn Therapeutics Inc.	27,326	$199,479

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$310,802	335	+0.3%	Shares	Sole	2026-08-05
2026-03-31	$243,903	334	-1.2%	Shares	Sole	2026-05-14
2025-12-31	$284,241	338	+2.7%	Shares	Sole	2026-01-23
2025-09-30	$242,657	329	—	Shares	Sole	2025-11-10
No filing history on record for this holder in this stock.